Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B E Hansen

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Gastroenterology|July 27, 1999
Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Eurohep Study Group for Viral HepatitisS W Schalm, O Weiland, B E Hansen, et al.
Journal of Viral Hepatitis|January 22, 2014
Loss of intrahepatic HBsAg expression predicts sustained response to peginterferon and is reflected by pronounced serum HBsAg declineP Arends, V Rijckborst, P E Zondervan, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 1998
Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic miceE C Andersson, B E Hansen, H Jacobsen, et al.
Alimentary Pharmacology & Therapeutics|September 14, 2012
Risk factors and outcome of HIV-associated idiopathic noncirrhotic portal hypertensionJ N L Schouten, M E Van der Ende, T Koëter, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|November 10, 2009
Long-term survival after perforated diverticulitisJ Vermeulen, M P Gosselink, W C J Hop, et al.
The Journal of Physiology|February 24, 2017
Leg vascular and skeletal muscle mitochondrial adaptations to aerobic high-intensity exercise training are enhanced in the early postmenopausal phaseMichael Nyberg, Jon Egelund, Camilla M Mandrup, et al.
Alimentary Pharmacology & Therapeutics|October 18, 2011
Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis CR J de Knegt, G Bezemer, A R Van Gool, et al.
Alimentary Pharmacology & Therapeutics|March 11, 2015
Reduced risk of relapse after long-term nucleos(t)ide analogue consolidation therapy for chronic hepatitis BH Chi, B E Hansen, C Yim, et al.
Gut|February 14, 2003
Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferaseA B van Nunen, B E Hansen, D J Suh, et al.
Journal of Viral Hepatitis|September 26, 2015
Peginterferon add-on results in more HBsAg decline compared to monotherapy in HBeAg-positive chronic hepatitis B patientsW P Brouwer, M J Sonneveld, Q Xie, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Gastroenterology|July 27, 1999
Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Eurohep Study Group for Viral HepatitisS W Schalm, O Weiland, B E Hansen, et al.
Journal of Viral Hepatitis|January 22, 2014
Loss of intrahepatic HBsAg expression predicts sustained response to peginterferon and is reflected by pronounced serum HBsAg declineP Arends, V Rijckborst, P E Zondervan, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 1998
Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic miceE C Andersson, B E Hansen, H Jacobsen, et al.
Alimentary Pharmacology & Therapeutics|September 14, 2012
Risk factors and outcome of HIV-associated idiopathic noncirrhotic portal hypertensionJ N L Schouten, M E Van der Ende, T Koëter, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|November 10, 2009
Long-term survival after perforated diverticulitisJ Vermeulen, M P Gosselink, W C J Hop, et al.
The Journal of Physiology|February 24, 2017
Leg vascular and skeletal muscle mitochondrial adaptations to aerobic high-intensity exercise training are enhanced in the early postmenopausal phaseMichael Nyberg, Jon Egelund, Camilla M Mandrup, et al.
Alimentary Pharmacology & Therapeutics|October 18, 2011
Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis CR J de Knegt, G Bezemer, A R Van Gool, et al.
Alimentary Pharmacology & Therapeutics|March 11, 2015
Reduced risk of relapse after long-term nucleos(t)ide analogue consolidation therapy for chronic hepatitis BH Chi, B E Hansen, C Yim, et al.
Gut|February 14, 2003
Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferaseA B van Nunen, B E Hansen, D J Suh, et al.
Journal of Viral Hepatitis|September 26, 2015
Peginterferon add-on results in more HBsAg decline compared to monotherapy in HBeAg-positive chronic hepatitis B patientsW P Brouwer, M J Sonneveld, Q Xie, et al.
Pageof 8